Target intelligence / Profile preview

Glutamic-oxaloacetic transaminase 1-like 1 (GOT1L1)

Target
GOT1L1
Molecular classification
Enzyme (putative aminotransferase family), Pyridoxal phosphate-dependent enzyme (PLP-dependent)
01

Overview

Glutamic-oxaloacetic transaminase 1-like 1 (GOT1L1) is a putative enzyme predicted to catalyze the transamination of L-aspartate and α-ketoglutarate to L-glutamate in humans. It is classified as a pyridoxal 5′-phosphate-dependent aminotransferase. Expression is highest in the testis, especially in spermatocytes and sperm, suggesting a possible role in spermatogenesis. Previous research proposed GOT1L1 as an aspartate racemase involved in d-aspartate synthesis, which has neurophysiological roles; however, more recent functional studies failed to confirm significant aspartate racemase activity and suggested only weak aminotransferase activity. To date, no clear disease associations, drug interactions, biomarker applications, or therapeutic utilities have been documented in humans.

Other names
Putative aspartate aminotransferase, cytoplasmic 2MGC33309Glutamate oxaloacetate transaminase 1-like protein 1Transaminase A-like protein 1GOT1L1
02

Mechanism of action

Not applicable, as no drugs target this molecule.

03

Biological functions

Aspartate transamination: predicted to catalyze transamination between L-aspartate and α-ketoglutarate to produce L-glutamatePotential role in aspartate biosynthetic processHigh expression in testis (possible involvement in spermatogenesis)Reported, but debated, involvement in d-aspartate production and possible neurogenesis in animal models

Beyond the preview

Go deeper on Glutamic-oxaloacetic transaminase 1-like 1 (GOT1L1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutamic-oxaloacetic transaminase 1-like 1 (GOT1L1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call